Press Releases on Generally Recognized as Safe (GRAS)

Aug 26 2024 08:00
CARLSBAD, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will exhibit at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan,...


Aug 20 2024 08:30
TEL AVIV, Israel, Aug. 20, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today...


Aug 07 2024 08:00
CARLSBAD, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented ingredients presents TriBsyn™, a groundbreaking new carnosine booster utilizing CarnoSyn®...


Jun 13 2024 08:30
Projects sales for Q4 2024 to increase more than 75% sequentially from Q3 2024, reflecting the prudent deployment of capital into sales and market initiatives following the IPO


May 02 2024 09:00
EPA Designates Forever Chemicals as Hazardous Substances Setting New Standards in Environmental Responsibility


Apr 29 2024 09:00
Omaha, NE, April 29, 2024 (GLOBE NEWSWIRE) -- CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of the patented aqueous ozone technology that works as an all-purpose...


Apr 15 2024 09:30
Global Food anti-caking agents market size was valued at around $822 million in 2020 and is predicted to reach $1,074 million by 2025.


Mar 13 2024 09:10
The demand for natural antioxidants and nutraceuticals is expected to rise due to reasons such as increased preference for dietary supplements due to the high expense of hospitalization and rising...


Feb 15 2024 11:00
CARLSBAD, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), today announced its expansion in Brazil with Barentz, creating an...


Feb 14 2024 08:00
Commercialization of Equivir anticipated after second trial is completed in Q2, 2024

0/5 (0 Reviews)

Don't miss updates from Health Canada and FDA.

If you are looking for the latest regulatory updates or want the newest regulatory requirements guides, please leave your email and we'll keep you posted.

What service are you interested in? *
We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.